Form D · Other Health Care
PharmAkea, Inc.
San Diego, CA · CIK 0001560523
Offering snapshot reported Oct 15, 2013 · SEC filing
- Reported sold
- $11.9M Offering amount: $12.9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2013 | Initial | $11,899,999 | No comparison | 7 | SEC filing |
| Oct 17, 2012 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204554
Of the $11,899,999.83 Total Amount Sold, $1,500,000.00 is the conversion of an outstanding convertible promissory note.
Source: Form D, filed Oct 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Daniels | Director |
| Jillian Evans | Executive |
| Carl Goldfischer | Director |
| Kevin Holme | Executive |
| John Hutchinson | Executive |
| Mervyn Turner | Director |
| Robert Williamson | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12780 El Camino Real Suite 200
San Diego, CA, 92130
San Diego, CA, 92130